ブックタイトルHealth Management for Female Athletes

ページ
83/90

このページは Health Management for Female Athletes の電子ブックに掲載されている83ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「ブックを開く」ボタンをクリックすると今すぐブックを開きます。

ActiBookアプリアイコンActiBookアプリをダウンロード(無償)

  • Available on the Appstore
  • Available on the Google play

概要

Health Management for Female Athletes

26. Zderic TW et al. Glucose kinetics and substrate oxidation during exercise in the follicular andluteal phases. J Appl Physiol, 90(2), 447-453, 2001.27. Peters C and Burrows M. Androgenicity of the progestin in oral contraceptives does not affectmaximal leg strength. Contraception, 74(6), 487-491, 2006.28. Ekenros L et al. Oral contraceptives do not affect muscle strength and hop performance in activewomen. Clin J Sport Med, 23(3), 202-207, 2003.29. Giacomoni M et al. Influence of the menstrual cycle phase and menstrual symptoms on maximalanaerobic performance. Med Sci Sports Exerc, 32(2), 486-492, 2000.30. Rechichi C and Dawson B. Effect of oral contraceptive cycle phase on performance in team sportplayers. J Sci Med Sport, 12(1), 190-195, 2009.31. Bushman B et al. Anaerobic power performance and the menstrual cycle: eumenorrheic and oralcontraceptive users. J Sports Med Phys Fitness, 46(1),132-137, 2006.32. Renstrom P et al. Non-contact ACL injuries in female athletes: an International OlympicCommittee current concepts statement. Br J Sports Med, 42(6), 394-412, 2008.33. Heitz NA et al. Hormonal changes throughout the menstrual cycle and increased anteriorcruciate ligament laxity in females. J Athl Train, 34(2), 144-149, 1999.34. Park SK et al. Alterations in knee joint laxity during the menstrual cycle in healthy women leadsto increases in joint loads during selected athletic movements. Am J Sports Med, 37(6), 1169-1177,2009.35. Dragoo JL et al. Relaxin receptors in the human female anterior cruciate ligament. Am J SportsMed, 31(4), 577-584;,2003.36. Dragoo JL et al. Prospective correlation between serum relaxin concentration and anteriorcruciate ligament tears among elite collegiate female athletes. Am J Sports Med, 39(10), 2175-2180, 2011.37. Dragoo JL et al. Trends in serum relaxin concentration among elite collegiate female athletes. IntJ Womens Health, 19(3), 19-24, 2011.38. Rechichi C et al. Athletic performance and the oral contraceptive. Int J Sports Physiol Perform,4(2), 51-62, 2009.39.能瀬さやから,婦人科疾患治療におけるドーピング禁止物質,臨床スポーツ医学, 33(2) , 192-197, 2016.40.世界ドーピング防止規程2016年禁止表国際基準:日本アンチ・ドーピング機構2016.81